NCT00480714View on ClinicalTrials.gov

A Study of the Immunogenicity of BCG, Delivered Intradermally in Healthy Volunteers

NACompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

March 31, 2003

Study Completion Date

September 30, 2003

Conditions
TB
Interventions
BIOLOGICAL

BCG (SSI Strain)

Trial Locations (1)

OX3 7LJ

University of Oxford, CCVTM, Churchill Hospital, Oxford

All Listed Sponsors
lead

University of Oxford

OTHER

NCT00480714 - A Study of the Immunogenicity of BCG, Delivered Intradermally in Healthy Volunteers | Biotech Hunter | Biotech Hunter